Phase 2 trial of a novel peptide vaccine targeting CMV antigen for newly diagnosed pediatric high grade glioma and diffuse intrinsic pontine glioma and recurrent medulloblastoma
Research Grant
Administered By
Neurosurgery
Awarded By
Food and Drug Administration
Start Date
September 20, 2021
End Date
August 31, 2027
Administered By
Neurosurgery
Awarded By
Food and Drug Administration
Start Date
September 20, 2021
End Date
August 31, 2027